caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1336252907

Ramon MarreroMD

GastroenterologyBayamon, PRI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
2,132
Beneficiaries
—
Total drug cost
$135K
Distinct drugs
23
Brand share
18.2%
Top prescribed drugs
Famotidine599 claims
Pantoprazole Sodium360 claims
Sucralfate263 claims
Omeprazole157 claims
Sod Sulf/Pot Chloride/Mag Sulf103 claims
REFERRAL NETWORK

Where Ramon Marrero's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 2 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Delba Garrastegui
Pathology · Bayamon, PR
1316
CENTRO MEDICO DEL TURABO, INC.1324
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
CENTRO MEDICO DEL TURABO, INC.1733
Delba Garrastegui
Pathology · Bayamon, PR
1429
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
54
Unique beneficiaries
—
Total services
79
Distinct HCPCS
2
Medicare payment
$5K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 141 Gastroenterology providers in PR — above median (cohort median 77).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.